Status:
TERMINATED
A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery
Lead Sponsor:
AbbVie
Conditions:
Cardiothoracic Surgery
Vascular Surgery
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.
Eligibility Criteria
Inclusion
- \- Patients undergoing high risk major surgery in subjects with cardiovascular disease who are at risk of AKI.
Exclusion
- Ongoing or recent history of sepsis
- Has recent documented acute kidney injury.
- Subject is scheduled to have a total or partial nephrectomy.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01897519
Start Date
May 1 2013
End Date
May 1 2014
Last Update
June 6 2014
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 96295
Gainesville, Florida, United States, 32610
2
Site Reference ID/Investigator# 96778
Jacksonville, Florida, United States, 32207
3
Site Reference ID/Investigator# 96301
Tampa, Florida, United States, 33613
4
Site Reference ID/Investigator# 96302
Fort Wayne, Indiana, United States, 46804